[{"path":[]},{"path":"https://epiverse-trace.github.io/etstats/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"CC0 1.0 Universal","title":"CC0 1.0 Universal","text":"CREATIVE COMMONS CORPORATION LAW FIRM PROVIDE LEGAL SERVICES. DISTRIBUTION DOCUMENT CREATE ATTORNEY-CLIENT RELATIONSHIP. CREATIVE COMMONS PROVIDES INFORMATION “-” BASIS. CREATIVE COMMONS MAKES WARRANTIES REGARDING USE DOCUMENT INFORMATION WORKS PROVIDED HEREUNDER, DISCLAIMS LIABILITY DAMAGES RESULTING USE DOCUMENT INFORMATION WORKS PROVIDED HEREUNDER.","code":""},{"path":"https://epiverse-trace.github.io/etstats/LICENSE.html","id":"statement-of-purpose","dir":"","previous_headings":"","what":"Statement of Purpose","title":"CC0 1.0 Universal","text":"laws jurisdictions throughout world automatically confer exclusive Copyright Related Rights (defined ) upon creator subsequent owner(s) (, “owner”) original work authorship /database (, “Work”). Certain owners wish permanently relinquish rights Work purpose contributing commons creative, cultural scientific works (“Commons”) public can reliably without fear later claims infringement build upon, modify, incorporate works, reuse redistribute freely possible form whatsoever purposes, including without limitation commercial purposes. owners may contribute Commons promote ideal free culture production creative, cultural scientific works, gain reputation greater distribution Work part use efforts others. /purposes motivations, without expectation additional consideration compensation, person associating CC0 Work (“Affirmer”), extent owner Copyright Related Rights Work, voluntarily elects apply CC0 Work publicly distribute Work terms, knowledge Copyright Related Rights Work meaning intended legal effect CC0 rights. Copyright Related Rights. Work made available CC0 may protected copyright related neighboring rights (“Copyright Related Rights”). Copyright Related Rights include, limited , following: right reproduce, adapt, distribute, perform, display, communicate, translate Work; moral rights retained original author(s) /performer(s); publicity privacy rights pertaining person’s image likeness depicted Work; rights protecting unfair competition regards Work, subject limitations paragraph 4(), ; rights protecting extraction, dissemination, use reuse data Work; database rights (arising Directive 96/9/EC European Parliament Council 11 March 1996 legal protection databases, national implementation thereof, including amended successor version directive); similar, equivalent corresponding rights throughout world based applicable law treaty, national implementations thereof. Waiver. greatest extent permitted , contravention , applicable law, Affirmer hereby overtly, fully, permanently, irrevocably unconditionally waives, abandons, surrenders Affirmer’s Copyright Related Rights associated claims causes action, whether now known unknown (including existing well future claims causes action), Work () territories worldwide, (ii) maximum duration provided applicable law treaty (including future time extensions), (iii) current future medium number copies, (iv) purpose whatsoever, including without limitation commercial, advertising promotional purposes (“Waiver”). Affirmer makes Waiver benefit member public large detriment Affirmer’s heirs successors, fully intending Waiver shall subject revocation, rescission, cancellation, termination, legal equitable action disrupt quiet enjoyment Work public contemplated Affirmer’s express Statement Purpose. Public License Fallback. part Waiver reason judged legally invalid ineffective applicable law, Waiver shall preserved maximum extent permitted taking account Affirmer’s express Statement Purpose. addition, extent Waiver judged Affirmer hereby grants affected person royalty-free, non transferable, non sublicensable, non exclusive, irrevocable unconditional license exercise Affirmer’s Copyright Related Rights Work () territories worldwide, (ii) maximum duration provided applicable law treaty (including future time extensions), (iii) current future medium number copies, (iv) purpose whatsoever, including without limitation commercial, advertising promotional purposes (“License”). License shall deemed effective date CC0 applied Affirmer Work. part License reason judged legally invalid ineffective applicable law, partial invalidity ineffectiveness shall invalidate remainder License, case Affirmer hereby affirms () exercise remaining Copyright Related Rights Work (ii) assert associated claims causes action respect Work, either case contrary Affirmer’s express Statement Purpose. Limitations Disclaimers. trademark patent rights held Affirmer waived, abandoned, surrendered, licensed otherwise affected document. Affirmer offers Work -makes representations warranties kind concerning Work, express, implied, statutory otherwise, including without limitation warranties title, merchantability, fitness particular purpose, non infringement, absence latent defects, accuracy, present absence errors, whether discoverable, greatest extent permissible applicable law. Affirmer disclaims responsibility clearing rights persons may apply Work use thereof, including without limitation person’s Copyright Related Rights Work. , Affirmer disclaims responsibility obtaining necessary consents, permissions rights required use Work. Affirmer understands acknowledges Creative Commons party document duty obligation respect CC0 use Work.","code":""},{"path":"https://epiverse-trace.github.io/etstats/articles/citations.html","id":"citations-of-epiverse-as-a-project","dir":"Articles","previous_headings":"","what":"Citations of Epiverse as a project","title":"Citations","text":"Lipsitch M, Bassett MT, Brownstein JS, Elliott P, Eyre D, Grabowski MK, Hay JA, Johansson MA, Kissler SM, Larremore DB, Layden JE, Lessler J, Lynfield R, MacCannell D, Madoff LC, Metcalf CJE, Meyers LA, Ofori SK, Quinn C, Bento AI, Reich NG, Riley S, Rosenfeld R, Samore MH, Sampath R, Slayton RB, Swerdlow DL, Truelove S, Varma JK, Grad YH (2024). “Infectious disease surveillance needs United States: lessons Covid-19.” Frontiers Public Health, 12. ISSN 2296-2565, doi:10.3389/fpubh.2024.1408193.  Fletcher , Wellcome Trust (2024). “Co-Designing Foundations Climate Sensitive Infectious Disease Community Practice [version 1; peer reviewed].” Wellcome Open Res, 9(92). doi:10.21955/WELLCOMEOPENRES.1115376.1.  Wellcome Trust (2024). “Detection & Attribution Climate Change Impacts Human Health [version 1; peer reviewed].” Wellcome Open Res, 9(245), 245. doi:10.21955/wellcomeopenres.1115387.1.  Morgan O, Redies , Rioja ZBL, Brownstein J, George D, Golding J, Hanefeld J, Horby P, Lee C, Mikhailov D, Philip W, Scarpino S, Tessema SK, Ihekweazu C (2022). “Innovations public health surveillance: updates forum convened Hub Pandemic Epidemic Intelligence, 2 3 February 2022.” Eurosurveillance, 27(15). doi:10.2807/1560-7917.ES.2022.27.15.2200302.","code":""},{"path":[]},{"path":"https://epiverse-trace.github.io/etstats/articles/citations.html","id":"bpmodels","dir":"Articles","previous_headings":"Package citations","what":"bpmodels","title":"Citations","text":"Whittaker C, Barnsley G, Olivera Mesa D, Laydon DJ, Tan CW, Zhu F, Johnson R, Doohan P, Nedjati-Gilani G, Winskill P, Hogan AB, Deol , Mukandavire C, Hauck K, Lye DCB, Wang L, Watson OJ, Ghani AC (2024). “Quantifying impact broadly protective sarbecovirus vaccine future SARS-X pandemic.” medRxiv. doi:10.1101/2024.08.12.24311730, https://www.medrxiv.org/content/early/2024/08/12/2024.08.12.24311730.full.pdf, https://www.medrxiv.org/content/early/2024/08/12/2024.08.12.24311730.","code":""},{"path":"https://epiverse-trace.github.io/etstats/articles/citations.html","id":"cfr","dir":"Articles","previous_headings":"Package citations","what":"cfr","title":"Citations","text":"Nilles EJ, Paulino CT, de St. Aubin M, Restrepo AC, Mayfield H, Dumas D, Finch E, Garnier S, Etienne MC, Iselin L, Duke W, Jarolim P, Oasan T, Yu J, Wan H, Peña F, Iihoshi N, Abdalla G, Lopez B, Cruz Ldl, Henríquez B, Espinosa-Bode , Puello YC, Durski K, Baldwin M, Baez AA, Merchant RC, Barouch DH, Skewes-Ramm R, Gutiérrez EZ, Kucharski , Lau CL (2022). “SARS-CoV-2 seroprevalence, cumulative infections, immunity symptomatic infection – multistage national household survey modelling study, Dominican Republic, June–October 2021.” Lancet Regional Health – Americas, 16. ISSN 2667-193X, doi:10.1016/j.lana.2022.100390, Publisher: Elsevier, 2023-12-06.","code":""},{"path":"https://epiverse-trace.github.io/etstats/articles/citations.html","id":"epidemics","dir":"Articles","previous_headings":"Package citations","what":"epidemics","title":"Citations","text":"Zeina Jamaluddine, Zhixi Chen, Hanan Abukmail, Sarah Aly, Shatha Elnakib, Gregory Barnsley, Fiona Majorin, Hannha Tong, Tak Igusa, Oona MR Campbell, Paul B. Spiegel, Francesco Checchi, Gaza Health Impact Projections Working Group (2024). “Crisis Gaza: Scenario-based Health Impact Projections.” Technical Report Report One: 7 February 6 August 2024, London School Hygiene Tropical Medicine, Johns Hopkins University. https://gaza-projections.org/gaza_projections_report.pdf.","code":""},{"path":"https://epiverse-trace.github.io/etstats/articles/citations.html","id":"epiparameter","dir":"Articles","previous_headings":"Package citations","what":"epiparameter","title":"Citations","text":"Charniga K, Park SW, Akhmetzhanov AR, Cori , Dushoff J, Funk S, Gostic KM, Linton NM, Lison , Overton CE, Pulliam JRC, Ward T, Cauchemez S, Abbott S (2024). “Best practices estimating reporting epidemiological delay distributions infectious diseases using public health surveillance healthcare data.” arXiv preprint. doi:10.48550/arXiv.2405.08841.","code":""},{"path":"https://epiverse-trace.github.io/etstats/articles/citations.html","id":"finalsize","dir":"Articles","previous_headings":"Package citations","what":"finalsize","title":"Citations","text":"Loster R (2024). Building Framework Assessing Policy Compliance Efficacy One Health: Insights COVID-19 Case Study. Master’s thesis, University Guelph. https://mathstat.uoguelph.ca/node/592.","code":""},{"path":"https://epiverse-trace.github.io/etstats/articles/citations.html","id":"serofoi","dir":"Articles","previous_headings":"Package citations","what":"serofoi","title":"Citations","text":"Menezes , Takahashi S, Routledge , Metcalf CJE, Graham AL, Hay JA (2023). “serosim: R package simulating serological data arising vaccination, epidemiological antibody kinetics processes.” PLOS Computational Biology, 19(8), 1-25. doi:10.1371/journal.pcbi.1011384.  Hay J, Routledge , Takahashi S (2023). “Serodynamics: review methods epidemiological inference using serological data.” OSF Preprints. doi:10.31219/osf.io/kqdsn.","code":""},{"path":"https://epiverse-trace.github.io/etstats/articles/github-statistics.html","id":"github-followers","dir":"Articles","previous_headings":"","what":"GitHub followers","title":"GitHub statistics","text":"Epiverse-TRACE GitHub organization currently 176 followers.","code":""},{"path":[]},{"path":"https://epiverse-trace.github.io/etstats/articles/github-statistics.html","id":"totals","dir":"Articles","previous_headings":"GitHub stars ⭐","what":"Totals","title":"GitHub statistics","text":"total, 218 stars across Epiverse-TRACE packages. stars come 137 unique users.","code":""},{"path":[]},{"path":"https://epiverse-trace.github.io/etstats/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Hugo Gruson. Author, maintainer, copyright holder.","code":""},{"path":"https://epiverse-trace.github.io/etstats/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Gruson H (2024). etstats: Collect Save Analytics 'Epiverse-TRACE' Packages. R package version 0.0.0.9000, https://github.com/epiverse-trace/etstats.","code":"@Manual{,   title = {etstats: Collect and Save Analytics of 'Epiverse-TRACE' Packages},   author = {Hugo Gruson},   year = {2024},   note = {R package version 0.0.0.9000},   url = {https://github.com/epiverse-trace/etstats}, }"},{"path":"https://epiverse-trace.github.io/etstats/index.html","id":"epiverse-trace-project-public-statistics","dir":"","previous_headings":"","what":"Collect and Save Analytics of Epiverse-TRACE Packages","title":"Collect and Save Analytics of Epiverse-TRACE Packages","text":"repository stores creates visualizations statistics Epiverse-TRACE project.","code":""}]
